Literature DB >> 23258783

Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.

Paul W Jones1, Lukasz Adamek, Gilbert Nadeau, Norbert Banik.   

Abstract

The 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy document recommends assessment of chronic obstructive pulmonary disease (COPD) using symptoms and future exacerbation risk, employing two score cut-points: COPD Assessment Test (CAT) score ≥ 10 or modified Medical Research Council dyspnoea scale (mMRC) grade ≥ 2. To explore the equivalence of these two symptom cut-points, the relationship between the CAT and the mMRC and St George's Respiratory Questionnaire (SGRQ), the Short-form Health Survey and the Functional Assessment of Chronic Illness Therapy Fatigue scores were retrospectively analysed using a primary care dataset. Data from 1817 patients (mean ± SD forced expiratory volume in 1 s 1.6 ± 0.6 L) showed a significant association between mMRC grades and all health status scores (ANOVA p<0.0001). mMRC grade 1 was associated with significant levels of health status impairment (SGRQ 39.4 ± 15.5 and CAT 15.7 ± 7.0); even patients with mMRC grade 0 had modestly elevated scores (SGRQ 28.5 ± 15.1 and CAT 11.7 ± 6.8). An mMRC grading ≥ 2 categorised 57.2% patients with low symptom (groups A and C) versus 17.2% with the CAT. Using the mMRC cut-point (≥ 1) resulted in similar GOLD group categorisations as the CAT (18.9%). The mMRC showed a clear relationship with health status scores; even low mMRC grades were associated with health status impairment. Cut-points of mMRC grade ≥ 1 and CAT score ≥ 10 were approximately equivalent in determining low-symptom patients. The GOLD assessment framework may require refinement.

Entities:  

Mesh:

Year:  2012        PMID: 23258783     DOI: 10.1183/09031936.00125612

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  66 in total

Review 1.  Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.

Authors:  Kunal Srivastava; Deepika Thakur; Sheetal Sharma; Yogesh Suresh Punekar
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

2.  The clinical chronic obstructive pulmonary disease questionnaire: cut point for GOLD 2013 classification.

Authors:  Samantha S C Kon; Jane L Canavan; Claire M Nolan; Sarah E Jones; Amy L Clark; Michael I Polkey; William D-C Man
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

3.  GOLD Stage and Treatment in COPD: A 500 Patient Point Prevalence Study.

Authors:  Katherine A Safka; Joshua Wald; Hongyu Wang; Luke McIvor; Andrew McIvor
Journal:  Chronic Obstr Pulm Dis       Date:  2016-12-22

4.  The 2014 Updated GOLD Strategy: A Comparison of the Various Scenarios.

Authors:  Sarah Wilke; Dionne E Smid; Martijn A Spruit; Daisy J A Janssen; Jean W M Muris; Thys van der Molen; Marjan van den Akker; Paul W Jones; Emiel F M Wouters; Frits M E Franssen
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

5.  Health Status of Patients With Chronic Obstructive Pulmonary Disease by Symptom Level.

Authors:  Jessica Marvel; Tzy-Chyi Yu; Robert Wood; Victoria S Higgins; Barry J Make
Journal:  Chronic Obstr Pulm Dis       Date:  2016-05-05

6.  Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease.

Authors:  Jae Seung Lee; Joon Beom Seo; Sang Min Lee; Tai Sun Park; Sei Won Lee; Yeon-Mok Oh; Ji-Hyun Lee; Eun-Kyung Kim; Tae-Hyung Kim; Joo Hun Park; Seung Soo Sheen; Seong Yong Lim; Ina Jung; Sang-Do Lee
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

7.  Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial.

Authors:  Afisi S Ismaila; Nancy Risebrough; Melanie Schroeder; Dhvani Shah; Alan Martin; Emma C Goodall; Kerigo Ndirangu; Gerard Criner; Mark Dransfield; David Mg Halpin; MeiLan K Han; David A Lomas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-29

8.  Classification and treatment of chronic obstructive pulmonary disease outpatients in China according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: comparison with GOLD 2014.

Authors:  Yanan Cui; Zhongshang Dai; Lijuan Luo; Ping Chen; Yan Chen
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

9.  COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Authors:  Katherine E Lowe; Elizabeth A Regan; Antonio Anzueto; Erin Austin; John H M Austin; Terri H Beaty; Panayiotis V Benos; Christopher J Benway; Surya P Bhatt; Eugene R Bleecker; Sandeep Bodduluri; Jessica Bon; Aladin M Boriek; Adel Re Boueiz; Russell P Bowler; Matthew Budoff; Richard Casaburi; Peter J Castaldi; Jean-Paul Charbonnier; Michael H Cho; Alejandro Comellas; Douglas Conrad; Corinne Costa Davis; Gerard J Criner; Douglas Curran-Everett; Jeffrey L Curtis; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Jennifer G Dy; Ashraf Fawzy; Margaret Fleming; Eric L Flenaugh; Marilyn G Foreman; Spyridon Fortis; Hirut Gebrekristos; Sarah Grant; Philippe A Grenier; Tian Gu; Abhya Gupta; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Lystra P Hayden; Craig P Hersh; Brian D Hobbs; Eric A Hoffman; James C Hogg; John E Hokanson; Karin F Hoth; Albert Hsiao; Stephen Humphries; Kathleen Jacobs; Francine L Jacobson; Ella A Kazerooni; Victor Kim; Woo Jin Kim; Gregory L Kinney; Harald Koegler; Sharon M Lutz; David A Lynch; Neil R MacIntye; Barry J Make; Nathaniel Marchetti; Fernando J Martinez; Diego J Maselli; Anne M Mathews; Meredith C McCormack; Merry-Lynn N McDonald; Charlene E McEvoy; Matthew Moll; Sarah S Molye; Susan Murray; Hrudaya Nath; John D Newell; Mariaelena Occhipinti; Matteo Paoletti; Trisha Parekh; Massimo Pistolesi; Katherine A Pratte; Nirupama Putcha; Margaret Ragland; Joseph M Reinhardt; Stephen I Rennard; Richard A Rosiello; James C Ross; Harry B Rossiter; Ingo Ruczinski; Raul San Jose Estepar; Frank C Sciurba; Jessica C Sieren; Harjinder Singh; Xavier Soler; Robert M Steiner; Matthew J Strand; William W Stringer; Ruth Tal-Singer; Byron Thomashow; Gonzalo Vegas Sánchez-Ferrero; John W Walsh; Emily S Wan; George R Washko; J Michael Wells; Chris H Wendt; Gloria Westney; Ava Wilson; Robert A Wise; Andrew Yen; Kendra Young; Jeong Yun; Edwin K Silverman; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11

10.  Blood RNA sequencing shows overlapping gene expression across COPD phenotype domains.

Authors:  Auyon J Ghosh; Aabida Saferali; Sool Lee; Robert Chase; Matthew Moll; Jarrett Morrow; Jeong Yun; Peter J Castaldi; Craig P Hersh
Journal:  Thorax       Date:  2021-06-24       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.